Response to BRAF and MEK Inhibitors in BRAF Thr599dup-Mutated Melanoma.
暂无分享，去创建一个
L. Machet | L. Mortier | V. Derangère | A. Jarrousse | S. Mansard | N. Kramkimel | A. Hervieu | P. Jamme | A. Greliak | C. Descarpentries | D. Dudoignon | Marion Oberlé